611.5500 -7.50 (-1.21%)
NSE Oct 23, 2026 15:31 PM
Volume: 534.2K
 

611.55
-1.21%
Axis Direct
We expect Gross Margins to be impacted due to an increase in revenue share from non-regulated markets and an increase in raw material prices going onwards. Hence, we recommend a HOLD rating on the stock with a target price of INR 1,670 (PE 20x for FY23EPS).
Solara Active Pharma has lost -15.92% in the last 1 Month
More from Solara Active Pharma Sciences Ltd.
Recommended